Please login to the form below

Not currently logged in
Email:
Password:

RSA name Kris Richards as senior consultant

Will aid the executive interims team

RSA Kris RichardsLife sciences recruitment firm RSA has named Kris Richards as senior consultant to the executive interims team.

Richards will be responsible for providing executive level interim services to existing and new clients.

Commenting on her appointment, Richards said: “I'm excited to have the opportunity to work with one of the world's leading life sciences executive interim specialists.

“At RSA, I will be able to use all my knowledge of the sector to make meaningful and productive appointments at the executive interim level.”

For the past 16 years, Richards has specialised in recruiting for the life sciences sector, supporting UK and western Europe-based organisations, holding the position of divisional manager of European operations at Lab Support and divisional manager of life sciences at Volt.

Dafydd Wright, director of interims at RSA, added: “Kris brings with her expert knowledge in life sciences contract recruiting and her know-how will be an asset to the interims team as our service offering grows.

“Her knowledge and pan-European experience will be invaluable as we continue to support our international clients across executive interims and executive search.”

13th April 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics